Last reviewed · How we verify
NCT03863379: SarcObeNDS
Sarcopenic Obesity in Neurodisabilities
trial testing whole body DXA in Sarcopenic Obesity in 150 participants. Completed in 15 May 2022.
15 June 2021
Quick facts
| Lead sponsor | Dionyssiotis, Yannis, M.D. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 150 |
| Start date | 2 May 2019 |
| Primary completion | 15 June 2021 |
| Estimated completion | 15 May 2022 |
| Sites | 1 location across Greece |
Drugs / interventions tested
- whole body DXA
Conditions studied
- Sarcopenic Obesity — all drugs for Sarcopenic Obesity →
- Spinal Cord Injuries — all drugs for Spinal Cord Injuries →
- Stroke — all drugs for Stroke →
- Multiple Sclerosis — all drugs for Multiple Sclerosis →
Sponsor
Dionyssiotis, Yannis, M.D.
Who can join
Adults 20 to 90, any sex, with Sarcopenic Obesity or Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To describe the frequency and thresholds for sarcopenic obesity in neurodisabled persons and the fat and lean mass distribution based on various neurodisabilities
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Sarcopenic Obesity in Individuals With Neurodisabilities: The SarcObeNDS Study.
Dionyssiotis Y, Prokopidis K, Trovas G, Papadatou MC, et al · · 2022 · cited 2× · PMID 35928890 · DOI 10.3389/fendo.2022.868298 -
Communications to the International Sarcopenia Translational Research Conference 2021.
· 2021 · PMID 34557616 · DOI 10.22540/jfsf-06-163
Verify or expand the search:
- PubMed search for NCT03863379
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sarcopenic Obesity
Currently open trials in the same condition.
- NCT07154719 — GLP-1R Actions on Muscle and the Skeleton · Phase 4 · recruiting
- NCT07035483 — Changes in Fat and Muscle Tissue Function and Their Impact on Metabolic Health After Bariatric Surgery · active not recruiting
- NCT06600581 — Safety and Efficacy of IMM01-STEM Against Placebo on Muscle Performance in Seniors With Obesity and Muscle Weakness · Phase 2 · active not recruiting
- NCT06826963 — Feasibility and Effectiveness of Eccentric Exercise in Sarcopenic Older Adults with Heart Failure: a Pilot Study · NA · recruiting
- NCT06822504 — Prevalence of Sarcopenic Obesity in COPD · recruiting
Other Dionyssiotis, Yannis, M.D. trials
Trials by the same sponsor.
- NCT04407819 — Sarcopenia and Diabetes Mellitus · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03863379 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dionyssiotis, Yannis, M.D.
- Last refreshed: 27 January 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03863379.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing